CZ49895A3 - Sulfated alpha-glycolipid derivatives as inhibitors of cellular adhesion - Google Patents

Sulfated alpha-glycolipid derivatives as inhibitors of cellular adhesion Download PDF

Info

Publication number
CZ49895A3
CZ49895A3 CZ95498A CZ49895A CZ49895A3 CZ 49895 A3 CZ49895 A3 CZ 49895A3 CZ 95498 A CZ95498 A CZ 95498A CZ 49895 A CZ49895 A CZ 49895A CZ 49895 A3 CZ49895 A3 CZ 49895A3
Authority
CZ
Czechia
Prior art keywords
octadecene
pharmaceutically acceptable
solvate
benzoyloxy
acceptable salt
Prior art date
Application number
CZ95498A
Other languages
Czech (cs)
English (en)
Inventor
Alain Martel
Jacques Banville
Alejandro A Aruffo
Original Assignee
Bristor Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristor Myers Squibb Company filed Critical Bristor Myers Squibb Company
Publication of CZ49895A3 publication Critical patent/CZ49895A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CZ95498A 1994-03-04 1995-02-24 Sulfated alpha-glycolipid derivatives as inhibitors of cellular adhesion CZ49895A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20592894A 1994-03-04 1994-03-04

Publications (1)

Publication Number Publication Date
CZ49895A3 true CZ49895A3 (en) 1995-12-13

Family

ID=22764246

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ95498A CZ49895A3 (en) 1994-03-04 1995-02-24 Sulfated alpha-glycolipid derivatives as inhibitors of cellular adhesion

Country Status (15)

Country Link
US (1) US5663151A (cg-RX-API-DMAC7.html)
EP (1) EP0671407A2 (cg-RX-API-DMAC7.html)
JP (1) JPH0841093A (cg-RX-API-DMAC7.html)
KR (1) KR950032258A (cg-RX-API-DMAC7.html)
CN (1) CN1112122A (cg-RX-API-DMAC7.html)
AU (1) AU1360595A (cg-RX-API-DMAC7.html)
CA (1) CA2142154A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ49895A3 (cg-RX-API-DMAC7.html)
FI (1) FI951001L (cg-RX-API-DMAC7.html)
HU (1) HUT70404A (cg-RX-API-DMAC7.html)
IL (1) IL112756A0 (cg-RX-API-DMAC7.html)
NO (1) NO950763L (cg-RX-API-DMAC7.html)
PL (1) PL307524A1 (cg-RX-API-DMAC7.html)
RU (1) RU95103100A (cg-RX-API-DMAC7.html)
ZA (1) ZA95937B (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU737680C (en) * 1996-05-16 2002-05-02 Nissin Foods Holdings Co., Ltd. Novel compounds having antiviral activity
US5700458A (en) 1996-09-20 1997-12-23 Geltex Pharmaceuticals Inc. Acid-functionalized saccharides as polyvalent anti-infectives
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
JP4716655B2 (ja) * 2001-11-21 2011-07-06 ユニバーシティ・オブ・オーフース 抗炎症剤としてのモノ−およびジアシルグリセロールのグリコシドの使用
US7060685B2 (en) * 2002-05-16 2006-06-13 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
JP2006502986A (ja) * 2002-07-03 2006-01-26 グリコミメティクス， インコーポレイテッド 新脈管形成に関与する医学的状態の診断および治療のための組成物および方法
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
US20050187171A1 (en) * 2003-11-19 2005-08-25 Glycomimetics, Inc. Glycomimetic antagonists for both E-and P-selectins
WO2005051920A2 (en) * 2003-11-19 2005-06-09 Glycomimetics, Inc. Specific antagonist for both e- and p-selectins
US7481080B2 (en) * 2004-07-01 2009-01-27 General Electric Company Clothes washer braking method and apparatus
DE102004036213B4 (de) * 2004-07-26 2011-02-24 Johannes-Gutenberg-Universität Mainz Nichtglykosidische und nichtpeptidische Selektininhibitoren, deren Herstellung und pharmazeutische Zusammensetzungen
AU2005322027B2 (en) * 2004-12-28 2013-09-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NK Tcells
US7923013B2 (en) * 2004-12-28 2011-04-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NKT cells
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
AU2006280101B2 (en) * 2005-08-09 2012-06-28 Glycomimetics, Inc. Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas
EP2264043B1 (en) * 2005-09-02 2017-11-08 GlycoMimetics, Inc. Heterobifunctional pan-selectin inhibitors
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
JP5298020B2 (ja) 2006-10-12 2013-09-25 グリコミメティクス， インコーポレイテッド ヘキソースおよびｎ−アセチルヘキソサミンの糖模倣体置換
WO2008100453A1 (en) * 2007-02-09 2008-08-21 Glycomimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
US8828952B2 (en) 2007-10-16 2014-09-09 Progen Pharmaceuticals Limited Sulfated oligosaccharide derivatives
US8895510B2 (en) * 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
CN102088983B (zh) * 2008-06-13 2013-01-30 糖模拟物有限公司 利用选择的糖模拟化合物的血液癌症的治疗
US8410066B2 (en) * 2009-05-01 2013-04-02 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
WO2013096926A1 (en) 2011-12-22 2013-06-27 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
ES2668045T3 (es) 2012-12-07 2018-05-16 Glycomimetics, Inc. Compuestos, composiciones y métodos que usan antagonistas de la E-selectina para la movilización de las células hematopoyéticas
US10519181B2 (en) 2014-12-03 2019-12-31 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
EP3405473A1 (en) 2016-01-22 2018-11-28 GlycoMimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
EP3522931A1 (en) 2016-10-07 2019-08-14 GlycoMimetics, Inc. Highly potent multimeric e-selectin antagonists
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体
EP3717013A1 (en) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CA3085356A1 (en) 2017-12-29 2019-07-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164388A (en) * 1966-06-14 1969-09-17 Shionogi & Co Crystalline Sulfur-Containing Glycolipid and the Production Thereof.
EP0146810A3 (de) * 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
DE3683214D1 (de) * 1985-08-13 1992-02-13 Solco Basel Ag Neues verfahren zur herstellung von sphingosinderivaten.
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
JPH0317020A (ja) * 1989-06-14 1991-01-25 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
EP0544815A1 (en) * 1990-07-17 1993-06-09 The Board Of Regents Of The University Of Oklahoma Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
WO1993005803A1 (en) * 1991-09-25 1993-04-01 Genetics Institute, Inc. Anti-inflammatory selectin inhibitors
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors

Also Published As

Publication number Publication date
FI951001A7 (fi) 1995-09-05
CA2142154A1 (en) 1995-09-05
NO950763D0 (no) 1995-02-28
HUT70404A (en) 1995-10-30
FI951001A0 (fi) 1995-03-03
HU9500655D0 (en) 1995-04-28
NO950763L (no) 1995-09-05
RU95103100A (ru) 1997-03-20
EP0671407A3 (cg-RX-API-DMAC7.html) 1995-10-25
AU1360595A (en) 1995-09-14
FI951001L (fi) 1995-09-05
JPH0841093A (ja) 1996-02-13
EP0671407A2 (en) 1995-09-13
CN1112122A (zh) 1995-11-22
US5663151A (en) 1997-09-02
KR950032258A (ko) 1995-12-20
ZA95937B (en) 1996-08-06
IL112756A0 (en) 1995-05-26
PL307524A1 (en) 1995-09-18

Similar Documents

Publication Publication Date Title
CZ49895A3 (en) Sulfated alpha-glycolipid derivatives as inhibitors of cellular adhesion
AU690358B2 (en) Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
US5783693A (en) Methods for synthesizing sulfated disaccharide inhibitors of selectins
US6503885B1 (en) Carboxymethylgalactose derivatives
US5763413A (en) Lewis-associated compound, process for producing the same, and anti-inflammatory
US5854218A (en) Sialyl Lex analogues as inhibitors of cellular adhesion
HUT74506A (en) Sialyl lewis-x analogues as inhibitors of cellular adhesion
US7875592B2 (en) Sulfated oligosaccharide derivatives
EP0536969A2 (en) Anti-endotoxin compounds
JPWO2000017216A1 (ja) カルボキシメチルガラクトース誘導体
EP0489162A1 (en) Derivative of glycolipid containing sialic acid
WO1997014707A1 (en) SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
US5565433A (en) Sulfated β-glycolipid derivatives as cell adhesion inhibitors
AU2007303858A1 (en) Anticoagulant compounds
EP1164140B1 (en) Novel sulfofucosylacylglycerol derivatives and utilization thereof as drugs
JP2766141B2 (ja) 酸性糖誘導体
Peter Wessel et al. The Synthesis of the 3′-and 3′′′-Monodeoxygenated Derivatives of β-Maltosyl-(1→ 4)-Trehalose
AU1633000A (en) Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
WO1998011118A1 (en) Lewis x derivatives
JPH06166696A (ja) フコシル‐グルコサミン誘導体
JPH1045793A (ja) 二量体化合物
JPH10152498A (ja) 糖脂質誘導体、それを有効成分とする免疫抑制剤およびその製造用中間体
TW200413400A (en) Lipid a derivatives which have glucose back-bone as the reducing sugar part
JP2004075670A (ja) グルコシルリピッドａ１位カルボキシメチル類縁体
JPH10195097A (ja) Ｃ−グリコシド誘導体